,token,ent,sent
0,Xinhua,0,0
1,News,0,0
2,Agency,0,0
3,",",0,0
4,Beijing,0,0
5,",",0,0
6,January,0,0
7,16th,0,0
8,",",0,0
9,by,0,0
10,reporter,0,1
11,Ye,0,1
12,Yuan,0,1
13,China,0,2
14,'s,0,2
15,pharmaceutical,0,2
16,enterprises,0,2
17,",",0,2
18,which,0,2
19,mainly,0,2
20,produce,0,2
21,large,0,2
22,amount,0,2
23,of,0,3
24,medicines,0,3
25,used,0,3
26,as,0,3
27,raw,0,3
28,materials,0,3
29,and,0,3
30,imitate,0,3
31,foreign,0,3
32,chemical,0,3
33,medicines,0,3
34,over,0,3
35,a,0,3
36,long,0,3
37,period,0,3
38,of,0,3
39,time,0,3
40,",",0,3
41,will,0,3
42,accelerate,0,3
43,the,0,3
44,development,0,3
45,of,0,3
46,new,0,3
47,medicines,0,3
48,and,0,3
49,technologies,0,3
50,with,0,3
51,their,0,3
52,own,0,3
53,intellectual,0,3
54,property,0,3
55,rights,0,3
56,.,0,3
57,An,0,4
58,official,0,4
59,from,0,4
60,the,ENTITY,4
61,State,ENTITY,4
62,Pharmaceutical,0,4
63,Administration,0,4
64,Bureau,0,4
65,said,0,4
66,that,0,4
67,",",0,5
68,starting,0,5
69,this,0,5
70,year,0,5
71,",",0,5
72,financial,0,5
73,aid,0,5
74,for,0,5
75,the,0,5
76,research,0,5
77,of,0,5
78,innovative,0,5
79,medicines,0,5
80,will,0,5
81,be,0,5
82,further,0,5
83,increased,0,5
84,",",0,5
85,and,0,5
86,State,0,5
87,-,0,5
88,owned,0,5
89,funds,0,5
90,would,0,5
91,give,0,5
92,investment,0,5
93,priority,0,5
94,to,0,5
95,the,0,5
96,fields,0,5
97,of,0,5
98,high,0,5
99,technology,0,5
100,and,0,5
101,innovated,0,5
102,medical,0,5
103,products,0,5
104,.,0,5
105,This,0,6
106,year,0,6
107,",",0,6
108,the,ENTITY,6
109,State,ENTITY,6
110,Pharmaceutical,0,6
111,Administration,0,6
112,Bureau,0,6
113,will,0,6
114,evaluate,0,6
115,and,0,7
116,decide,0,7
117,the,0,7
118,top,0,7
119,50,0,7
120,enterprises,0,7
121,in,0,7
122,the,0,7
123,pharmaceutical,0,7
124,industry,0,7
125,according,0,7
126,to,0,7
127,new,0,7
128,criteria,0,7
129,.,0,7
130,Total,0,8
131,annual,0,8
132,sales,0,8
133,revenue,0,8
134,is,0,8
135,predicted,0,8
136,to,0,8
137,be,0,8
138,more,0,8
139,than,0,8
140,60,0,9
141,%,0,9
142,of,0,9
143,the,0,9
144,whole,0,9
145,country,0,9
146,'s,0,9
147,medicine,0,9
148,sales,0,9
149,revenue,0,9
150,.,0,9
151,At,0,10
152,the,0,10
153,same,0,10
154,time,0,10
155,",",0,10
156,3,0,10
157,-,0,10
158,5,0,10
159,%,0,10
160,of,0,10
161,each,0,11
162,enterprise,0,11
163,'s,0,11
164,annual,0,11
165,sales,0,11
166,revenue,0,11
167,will,0,11
168,be,0,11
169,used,0,11
170,for,0,11
171,the,0,11
172,research,0,11
173,and,0,11
174,development,0,11
175,of,0,11
176,new,0,11
177,medicines,0,11
178,.,0,11
179,This,0,12
180,official,0,12
181,said,0,12
182,that,0,12
183,",",0,12
184,at,0,12
185,the,0,12
186,same,0,12
187,time,0,12
188,",",0,12
189,the,0,13
190,State,0,13
191,should,0,13
192,also,0,13
193,guide,0,13
194,foreign,0,13
195,capital,0,13
196,to,0,13
197,invest,0,13
198,in,0,13
199,new,0,13
200,technologies,0,13
201,",",0,13
202,new,0,13
203,products,0,13
204,and,0,13
205,medicine,0,13
206,projects,0,13
207,in,0,13
208,the,0,13
209,Midwest,0,13
210,area,0,13
211,",",0,13
212,to,0,13
213,give,0,13
214,impetus,0,13
215,to,0,13
216,national,0,13
217,medicine,0,13
218,enterprises,0,13
219,to,0,13
220,improve,0,13
221,products,0,13
222,',0,13
223,technical,0,13
224,content,0,13
225,and,0,13
226,enhance,0,13
227,competitiveness,0,13
228,in,0,13
229,the,0,13
230,international,0,13
231,market,0,13
232,.,0,13
233,China,0,14
234,now,0,14
235,has,0,14
236,about,0,14
237,"3,500",0,14
238,pharmaceutical,0,14
239,enterprises,0,14
240,",",0,14
241,which,0,14
242,produce,0,14
243,"1,350",0,15
244,kinds,0,15
245,of,0,15
246,medicines,0,15
247,used,0,15
248,as,0,15
249,raw,0,15
250,materials,0,15
251,and,0,15
252,"4,000",0,15
253,kinds,0,15
254,of,0,15
255,Chinese,0,15
256,herbal,0,15
257,medicines,0,15
258,each,0,15
259,year,0,15
260,",",0,15
261,and,0,15
262,is,0,15
263,the,0,15
264,second,0,15
265,largest,0,15
266,producing,0,15
267,and,0,15
268,exporting,0,15
269,country,0,15
270,of,0,15
271,medicines,0,15
272,used,0,15
273,as,0,15
274,raw,0,15
275,materials,0,15
276,",",0,15
277,second,0,15
278,only,0,15
279,to,0,15
280,America,0,15
281,.,0,15
282,But,0,16
283,due,0,16
284,to,0,16
285,science,0,16
286,and,0,16
287,technology,0,16
288,content,0,16
289,being,0,16
290,low,0,16
291,",",0,16
292,the,0,17
293,product,0,17
294,'s,0,17
295,sales,0,17
296,price,0,17
297,on,0,17
298,the,0,17
299,international,0,17
300,market,0,17
301,is,0,17
302,20,0,17
303,-,0,17
304,30,0,17
305,%,0,17
306,lower,0,17
307,than,0,17
308,the,0,17
309,normal,0,17
310,price,0,17
311,",",0,17
312,and,0,17
313,can,0,17
314,only,0,17
315,return,0,17
316,more,0,17
317,than,0,17
318,1,0,17
319,billion,0,17
320,US,0,17
321,dollars,0,17
322,in,0,17
323,foreign,0,17
324,currency,0,17
325,each,0,17
326,year,0,17
327,.,0,17
328,While,0,18
329,in,0,18
330,1996,0,18
331,",",0,18
332,importing,0,18
333,pharmaceutical,0,18
334,preparations,0,18
335,alone,0,18
336,consumed,0,18
337,funds,0,18
338,surpassing,0,19
339,1.1,0,19
340,billion,0,19
341,US,0,19
342,dollars,0,19
343,in,0,19
344,China,0,19
345,.,0,19
346,Now,0,20
347,",",0,20
348,in,0,20
349,China,0,20
350,",",0,20
351,there,0,20
352,are,0,20
353,less,0,20
354,than,0,20
355,"3,000",0,20
356,full,0,21
357,time,0,21
358,personnel,0,21
359,engaging,0,21
360,in,0,21
361,the,0,21
362,research,0,21
363,of,0,21
364,innovated,0,21
365,medicines,0,21
366,",",0,21
367,only,0,21
368,corresponding,0,21
369,to,0,21
370,personnel,0,21
371,on,0,21
372,the,0,21
373,regular,0,21
374,payroll,0,21
375,of,0,21
376,the,0,21
377,research,0,21
378,department,0,21
379,of,0,21
380,Merck,0,21
381,Pharmaceutical,0,21
382,Company,0,21
383,of,0,21
384,the,0,21
385,US,0,21
386,.,0,21
387,Experts,0,22
388,urge,0,22
389,that,0,22
390,China,0,22
391,'s,0,22
392,pharmaceutical,0,22
393,industry,0,22
394,should,0,22
395,change,0,22
396,methods,0,22
397,of,0,23
398,focusing,0,23
399,on,0,23
400,the,0,23
401,production,0,23
402,of,0,23
403,medicines,0,23
404,used,0,23
405,as,0,23
406,raw,0,23
407,materials,0,23
408,",",0,23
409,while,0,23
410,paying,0,23
411,less,0,23
412,attention,0,23
413,to,0,23
414,development,0,23
415,of,0,23
416,preparations,0,23
417,",",0,23
418,and,0,23
419,catching,0,23
420,up,0,23
421,with,0,23
422,development,0,23
423,trends,0,23
424,of,0,23
425,the,0,23
426,global,0,23
427,pharmaceutical,0,23
428,industry,0,23
429,as,0,23
430,soon,0,23
431,as,0,23
432,possible,0,23
433,.,0,23
434,It,0,24
435,was,0,24
436,learned,0,24
437,that,0,24
438,",",0,24
439,the,0,24
440,national,0,24
441,project,0,24
442,of,0,24
443,new,0,24
444,medicines,0,25
445,and,0,25
446,industrialized,0,25
447,development,0,25
448,",",0,25
449,jointly,0,25
450,promoted,0,25
451,by,0,25
452,departments,0,25
453,of,0,25
454,the,0,25
455,State,0,25
456,Science,0,25
457,Commission,0,25
458,",",0,25
459,the,0,25
460,Ministry,0,25
461,of,0,25
462,Public,0,25
463,Health,0,25
464,",",0,25
465,the,ENTITY,25
466,State,ENTITY,25
467,Pharmaceutical,0,25
468,Administration,0,25
469,Bureau,0,25
470,",",0,25
471,etc.,0,25
472,",",0,25
473,is,0,25
474,now,0,25
475,being,0,25
476,implemented,0,25
477,.,0,25
478,By,0,26
479,the,0,26
480,end,0,26
481,of,0,26
482,this,0,26
483,century,0,26
484,",",0,26
485,ten,0,26
486,new,0,26
487,patent,0,26
488,protected,0,27
489,medicines,0,27
490,are,0,27
491,planned,0,27
492,to,0,27
493,be,0,27
494,developed,0,27
495,and,0,27
496,five,0,27
497,new,0,27
498,medicine,0,27
499,selecting,0,27
500,centers,0,27
501,",",0,27
502,five,0,27
503,medication,0,27
504,safety,0,27
505,assessing,0,27
506,centers,0,27
507,and,0,27
508,five,0,27
509,medication,0,27
510,clinic,0,27
511,experimentation,0,27
512,centers,0,27
513,will,0,27
514,be,0,27
515,built,0,27
516,.,0,27
517,-LRB-,0,28
518,End,0,28
519,-RRB-,0,28
